LifeMD, Inc. LFMDP
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -1.77%
- 1 year
- -9.75%
- Open
- 21.65
- Prev close
- 21.83
- Mkt cap
- 148.31M
- Vol
- 111
- Avg vol
- 1.64K
- EPS
- -2.26
- P/E
- 0.00
- Div yield
- 9.97%
More statistics
- Low
- 21.65
- High
- 21.65
- Forward P/E
- 0.00
- Beta
- 1.23
- Short ratio
- 0.50
- Inst. own
- 0.00%
- Dividend
- 2.22
- Ex-div date
- Oct 3, 2024
- 50-d avg
- 22.40
- 200-d avg
- 22.28
- 1y target
- 0.00
News
1 month ago globenewswire.com
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that its Board of Directors has authorized…
2 months ago globenewswire.com
UPDATE - LifeMD Reports Second Quarter 2026 Results
UPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue of $47.3 million, within the Company's guidance range of $47 million to $50 million; adjusted…
3 months ago globenewswire.com
LifeMD to Report Second Quarter 2026 Financial Results on August 5
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six…
4 months ago globenewswire.com
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to…
4 months ago globenewswire.com
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program,…
5 months ago globenewswire.com
LifeMD Appoints Umesh Sripad as Chief Technology Officer
Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth Seasoned Technology Executive Brings More Than Two…
5 months ago globenewswire.com
LifeMD to Participate in Upcoming Investor Conferences
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming…
5 months ago seekingalpha.com
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
6 months ago globenewswire.com
LifeMD to Report First Quarter 2026 Financial Results on May 6
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months…
6 months ago globenewswire.com
LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® LifeMD expands its weight…
7 months ago globenewswire.com
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program
Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD's collaboration with Novo Nordisk Delivering up to $1,200 in annual patient savings on branded GLP-1…
7 months ago globenewswire.com
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash…
7 months ago seekingalpha.com
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
7 months ago globenewswire.com
LifeMD Reports Fourth Quarter and Full Year 2025 Results
Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million. Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
8 months ago globenewswire.com
LifeMD to Participate in Two Investor Conferences During March
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following…
8 months ago globenewswire.com
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12…
9 months ago globenewswire.com
LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced the closing of a new senior secured…
9 months ago globenewswire.com
LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill
Adds first and only FDA‑approved oral GLP‑1 to its virtual weight management offering, expanding access to affordable, branded treatment options Adds first and only FDA‑approved oral GLP‑1 to its…
10 months ago globenewswire.com
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has…
10 months ago defenseworld.net
LifeMD (NASDAQ:LFMDP) Trading 0.5% Higher – Time to Buy?
LifeMD, Inc. (NASDAQ: LFMDP - Get Free Report)'s share price traded up 0.5% on Thursday. The company traded as high as $22.63 and last traded at $22.75. 656 shares changed hands during mid-day…
-
1 year ago benzinga.com
LifeMD Q2 EPS $(0.06) Misses $(0.01) Estimate, Sales $62.200M Miss $66.343M Estimate
LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 900 percent. This is a 200 percent decrease over earnings of $0.06 per…